Palliative care pharmacotherapy literature summaries and analyses

J Pain Palliat Care Pharmacother. 2007;21(3):91-7.

Abstract

Timely and important studies are reviewed and commentaries provided by leading palliative care clinicians. Symptoms and treatment side effects addressed in this issue are: cardiovascular risk due to NSAIDs or COX-2 inhibitors; prolongation of the QT interval due to methadone use; depression and its treatment with scopolamine; adverse drug reactions related to cardiovascular medications, and their association with ethnicity; and medication nonadherence in Medicare enrollees due to cost considerations.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Cardiovascular Diseases / chemically induced
  • Clinical Trials as Topic
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Depressive Disorder, Major / drug therapy*
  • Humans
  • Methadone / adverse effects
  • Muscarinic Antagonists / therapeutic use*
  • Pain / drug therapy*
  • Palliative Care / methods*
  • Scopolamine / therapeutic use*

Substances

  • Analgesics, Opioid
  • Cyclooxygenase 2 Inhibitors
  • Muscarinic Antagonists
  • Scopolamine
  • Methadone